Inactive Instrument
Sector Celltrion, Inc. Korea S.E.
Stocks
068270
KR7068270008
Biotechnology & Medical Research
|
End-of-day quote
Korea S.E.
|
||
| - KRW | - |
|
| 08-25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| 08-24 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.10% | +0.44% | +5.18% | +18.44% | +9.41% | +2.80% | +24.32% | -24.35% | +214.15% | 51.14B | |
| +2.65% | +4.45% | +17.59% | +44.54% | +177.65% | +481.36% | +567.32% | +675.69% | - | 47.4B | |
| +0.33% | +2.47% | +23.06% | +58.42% | +16.40% | +38.97% | +19.80% | +1.09% | +246.65% | 43.19B | |
| -0.88% | +0.90% | +14.30% | +24.16% | +22.61% | +24.11% | +87.74% | +32.10% | +1,230.80% | 42.35B | |
| -2.27% | -3.02% | +6.76% | +0.19% | +9.99% | +14.22% | +51.50% | -18.22% | +145.06% | 33.23B | |
| -1.21% | -0.17% | +3.77% | +42.89% | +8.89% | +29.16% | +135.38% | +238.56% | +2,154.22% | 17.07B | |
| -0.36% | -2.14% | -1.60% | +5.99% | - | - | - | - | - | 16.38B | |
| +0.25% | +0.25% | +9.09% | +16.87% | +16.99% | +12.03% | +30.68% | -38.58% | +98.83% | 14.76B | |
| +0.44% | +1.70% | +32.15% | +80.20% | +48.59% | +82.07% | +47.92% | -32.13% | +256.65% | 14.15B | |
| +0.47% | -2.61% | +0.56% | +43.28% | -6.86% | -2.46% | -33.79% | -33.10% | +125.42% | 13.09B | |
| +3.23% | +6.06% | +64.74% | +49.86% | +19.71% | -3.47% | - | - | - | 12.75B | |
| +0.12% | +0.26% | +1.19% | +50.70% | +23.23% | +28.90% | -9.59% | -41.44% | +174.30% | 11.36B | |
| +3.48% | -9.25% | +20.48% | +79.99% | +63.28% | +45.88% | +63.80% | -46.57% | - | 11.29B | |
| -0.45% | -0.25% | -11.70% | -11.08% | -16.99% | +45.28% | +487.94% | +242.29% | +2,386.32% | 10.89B | |
| -2.52% | +0.90% | +16.48% | +3.00% | +24.80% | +683.99% | +1,534.89% | +23.61% | - | 10.27B | |
| -1.47% | +6.25% | +11.56% | -18.38% | -21.08% | +46.04% | +54.84% | +57.53% | +102.04% | 10.37B | |
| -4.24% | -1.05% | +9.25% | +47.16% | +54.52% | +184.50% | +512.17% | +99.52% | - | 10B | |
| +0.01% | +0.16% | +0.51% | +73.58% | +78.80% | +257.13% | +468.25% | - | - | 10.18B | |
| -1.80% | +1.05% | +107.02% | +149.28% | +180.19% | +104.95% | +87.10% | -6.83% | +1,605.88% | 9.9B | |
| Average | -0.22% | +0.92% | +17.39% | +39.95% | +39.45% | +115.30% | +242.96% | +70.57% | +728.36% | 20.52B | |
| Weighted average by Cap. | -0.01% | +1.07% | +15.26% | +35.71% | +43.15% | +113.12% | +195.27% | +107.30% | +615.02% |
- Stock Market
- Stocks
- A068270 Stock
- 068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
